Produced in partnership with IBTV, our Roving Reporter series captures real-time perspectives from across the life sciences industry. Filmed on the floor at Terrapinn’s Advanced Therapies London 2026, this episode brings together leading voices from across cell and gene therapy to ask what comes next for advanced therapies – and which emerging approaches could expand their impact across more patient populations.

Featuring insights from Raphael Ognar of NKILT Therapeutics, Nina Bauer of FUJIFILM Cellular Dynamics, Claudio Panzarella of ReiThera, Ibon Garitaonandia of CellProthera, Natalia Elizalde of VIVEbiotech, Felix Montero Julian of Accellix, Dominic Clarke of Cryoport Systems, Alexander Seyf of Autolomous, Alan Griffith of VectorBuilder, Marianna Mainardi Koga of Bracco, Shrinidh Joshi of Cell Therapies Pty Ltd, Manuel Balbuena of eXmoor Pharma, Julian Dye of Oxartis, and others, the discussion highlights a move beyond traditional ex vivo approaches toward a broader and more flexible toolkit – including in vivo cell therapies, gene editing, nucleic acid-based therapeutics, iPSC-derived therapies, exosomes, and bioengineered materials.

Watch the video below.

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

I have read and understand the Privacy Notice*

Subscribe